@article{ATM26559,
author = {André J. Scheen},
title = {Cardiovascular and renal protection with sodium-glucose cotransporter type 2 inhibitors: new paradigm in type 2 diabetes management…and potentially beyond},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {Sodium-glucose cotransporter type 2 inhibitors (SGLT2is) are new glucose-lowering agents that enhance glucosuria independently of insulin (1). They improve glucose control in patients with type 2 diabetes mellitus (T2DM) by reducing both fasting and postprandial hyperglycemia, with a minimal risk of hypoglycemia.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/26559}
}